Janus Henderson Group
CCXI

Janus Henderson Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Janus Henderson Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-132,739
Closed -$6.86M – 2634
2022
Q3 		$6.86M Buy
132,739
+122,785
+1,234% +$5.07M 0.01% 766
2022
Q2 		$246K Buy
9,954
+57
+0.6% +$1.26K ﹤0.01% 2204
2022
Q1 		$248K Buy
9,897
+1
+0% +$28 ﹤0.01% 2334
2021
Q4 		$361K Buy
+9,896
New +$347K ﹤0.01% 2103

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Janus Henderson Group's CCXI Position: Q4 2022 in Review

Janus Henderson Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 132,739 shares — an estimated $6.86M sold.

Janus Henderson Group first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $6.86M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Janus Henderson Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Janus Henderson Group sold 132,739 ChemoCentryx, Inc. shares in Q4 2022, an estimated $6.86M.
  • Janus Henderson Group first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
  • Janus Henderson Group's ChemoCentryx, Inc. position peaked at $6.86M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.